<DOC>
	<DOCNO>NCT00543959</DOCNO>
	<brief_summary>A study evaluate effectiveness tolerability MK0533 pioglitazone patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Efficacy Tolerability MK0533 Patients With Type 2 Diabetes ( 0533-005 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Patients age 18 70 year Type 2 diabetes able adequately control blood glucose level Note : Only patient take antihyperglycemic medicine 3 month screen Patients take medicine affect body fluid level diuretic water pill Patients take niacin certain medication Patients follow condition : liver kidney disease , poorly control high blood pressure , heart disease certain blood disorder Patients abnormal laboratory result blood test give patient start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>